News & Events
SEATTLE, Sept. 09, 2021 (GLOBE NEWSWIRE) — Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, with an initial focus on the central nervous system, today announced…
READ MORE
September 24, 2018 — Thank you to everyone at Impel who gave their time to United Way of King County’s Day of Caring last Friday. The team volunteered to help spruce up B.F. Day Elementary in Fremont for a new school year.…
READ MORE
August 24, 2008 — In 2008, Dr. John Hoekman was a Ph.D. student in pharmaceutics who had just won a UW business plan competition and was granted $25,000 to start his company. It’s been ten years since the incorporation of Impel…
READ MORE
